BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23204235)

  • 1. Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer.
    Chou CH; Yang NK; Liu TY; Tai SK; Hsu DS; Chen YW; Chen YJ; Chang CC; Tzeng CH; Yang MH
    Cancer Res; 2013 Jan; 73(2):953-66. PubMed ID: 23204235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells.
    Elkhadragy L; Chen M; Miller K; Yang MH; Long W
    Mol Oncol; 2017 Feb; 11(2):194-207. PubMed ID: 28079973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.
    Yang LY; He CY; Chen XH; Su LP; Liu BY; Zhang H
    Oncotarget; 2016 Jul; 7(30):48346-48359. PubMed ID: 27356739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.
    Baba Y; Nosho K; Shima K; Irahara N; Kure S; Toyoda S; Kirkner GJ; Goel A; Fuchs CS; Ogino S
    Neoplasia; 2009 May; 11(5):418-25. PubMed ID: 19412426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma.
    Chen C; Song G; Xiang J; Zhang H; Zhao S; Zhan Y
    Biochem Biophys Res Commun; 2017 Apr; 486(2):514-520. PubMed ID: 28322787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
    Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
    Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
    Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer.
    Wang J; Nikhil K; Viccaro K; Chang L; White J; Shah K
    BMC Biol; 2017 Feb; 15(1):10. PubMed ID: 28193222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner.
    Jia L; Lee HS; Wu CF; Kundu J; Park SG; Kim RN; Wang LH; Erkin ÖC; Choi JS; Chae SW; Yang HB; Choi YL; Shin YK
    Mol Cancer Res; 2014 Dec; 12(12):1779-95. PubMed ID: 25061104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.
    Dimri M; Cho JH; Kang M; Dimri GP
    J Biol Chem; 2015 Jan; 290(5):3033-44. PubMed ID: 25505268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
    Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
    Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.
    Wu KJ; Yang MH
    Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition.
    Yang MH; Hsu DS; Wang HW; Wang HJ; Lan HY; Yang WH; Huang CH; Kao SY; Tzeng CH; Tai SK; Chang SY; Lee OK; Wu KJ
    Nat Cell Biol; 2010 Oct; 12(10):982-92. PubMed ID: 20818389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    M JR; S V
    Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
    Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
    Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of stable knockdown of Aurora kinase A on proliferation, migration, chromosomal instability, and expression of focal adhesion kinase and matrix metalloproteinase-2 in HEp-2 cells.
    Zhang H; Chen X; Liu B; Zhou L
    Mol Cell Biochem; 2011 Nov; 357(1-2):95-106. PubMed ID: 21590355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.
    Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY
    Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.
    Wang H; Zhang G; Zhang H; Zhang F; Zhou B; Ning F; Wang HS; Cai SH; Du J
    Eur J Pharmacol; 2014 Jan; 723():156-66. PubMed ID: 24333218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.